UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.18786-18796

2023

Volltextzugriff (PDF)

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Nature genetics, 2020-01, Vol.52 (1), p.56-73

2020

Volltextzugriff (PDF)

Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)

European journal of human genetics : EJHG, 2024-09, Vol.32 (9), p.1166-1183

2024

Volltextzugriff (PDF)

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

Nature communications, 2016-09, Vol.7 (1), p.12675-22, Article 12675

2016

Volltextzugriff (PDF)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Nature communications, 2021-02, Vol.12 (1), p.1078-22, Article 1078

2021

Volltextzugriff (PDF)

Patient satisfaction, experience and preferences in the implementation of genetics teleconsultations in the North-eastern region of France

European journal of medical genetics, 2023-10, Vol.66 (10), p.104841-104841, Article 104841

2023

Volltextzugriff (PDF)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Nature communications, 2021-05, Vol.12 (1), p.2986-2, Article 2986

2021

Volltextzugriff (PDF)

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

BMC medical research methodology, 2021-07, Vol.21 (1), p.1-155, Article 155

2021

Volltextzugriff (PDF)

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

BMC medical research methodology, 2021-07, Vol.21 (1)

2021

Volltextzugriff (PDF)

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e13116-e13116

2016

Volltextzugriff (PDF)

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

Frontiers in oncology, 2018-10, Vol.8, p.490-490

2018

Volltextzugriff (PDF)

Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next‐generation sequencing

American journal of medical genetics. Part A, 2017-02, Vol.173 (2), p.531-536

2017

Volltextzugriff (PDF)

Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene

European journal of human genetics : EJHG, 2014-08, Vol.22 (8), p.979-987

2014

Volltextzugriff (PDF)

The FANCM:p.Arg658 truncating variant is associated with risk of triple-negative breast cancer

NPJ breast cancer, 2019, Vol.5 (1), p.38-14, Article 38

2019

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles

Patient satisfaction, experience and preferences in the implementation of genetics teleconsultations in the North-eastern region of France

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next‐generation sequencing

Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene

The FANCM:p.Arg658 truncating variant is associated with risk of triple-negative breast cancer

Suchergebnisse filtern